Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - apixaban, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; sodium lauryl sulfate; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - apixaban cipla is indicated for the prevention of venous thromboembolic events (vte) in adult patients who have undergone elective total hip or total knee replacement surgery.,apixaban cipla is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,apixaban cipla is indicated for the treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) in adult patients.,apixaban cipla is indicated for the prevention of recurrent dvt and pe in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - apixaban, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose; sodium lauryl sulfate; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow - eliquis is indicated for the prevention of venous thromboembolic events (vte) in adult patients who have undergone elective total hip or total knee replacement surgery.,eliquis is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,eliquis is indicated for the treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) in adult patients.,eliquis is indicated for the prevention of recurrent dvt and pe in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - apixaban, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; sodium lauryl sulfate; magnesium stearate; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - apixaban cipla is indicated for the prevention of venous thromboembolic events (vte) in adult patients who have undergone elective total hip or total knee replacement surgery.,apixaban cipla is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,apixaban cipla is indicated for the treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) in adult patients.,apixaban cipla is indicated for the prevention of recurrent dvt and pe in adult patients.

Malta - English - Medicines Authority

combino pharma (malta) ltd. hf60, hal far industrial estate, bbg07, hal far, malta - apixaban - film-coated tablet - apixaban 5 mg - antithrombotic agents

Malta - English - Medicines Authority

combino pharma (malta) ltd. hf60, hal far industrial estate, bbg07, hal far, malta - apixaban - film-coated tablet - apixaban 2.5 mg - antithrombotic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - apixaban, quantity: 5 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; microcrystalline cellulose; lactose; purified water; magnesium stearate; croscarmellose sodium; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide red - eliquis is indicated for the prevention of venous thromboembolic events (vte) in adult patients who have undergone elective total hip or total knee replacement surgery.,eliquis is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,eliquis is indicated for the treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) in adult patients.,eliquis is indicated for the prevention of recurrent dvt and pe in adult patients.

Malta - English - Medicines Authority

denk pharma gmbh & co. kg prinzregentenstrasse 79 81675 münchen , germany - apixaban - film-coated tablet - apixaban 2.5 mg - antithrombotic agents

Malta - English - Medicines Authority

denk pharma gmbh & co. kg prinzregentenstrasse 79 81675 münchen , germany - apixaban - film-coated tablet - apixaban 5 mg - antithrombotic agents

Israel - English - Ministry of Health

teva israel ltd - apixaban - film coated tablets - apixaban 2.5 mg - apixaban - prevention of venous thromboembolic events (vte) in adult patients who have undergone elective hip or knee replacement surgery. prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ≥ ii). treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

Israel - English - Ministry of Health

teva israel ltd - apixaban - film coated tablets - apixaban 5 mg - apixaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ≥ ii).treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), in adults.